Qyuns Therapeutics Co., Ltd. (HKG:2509)

Hong Kong · Delayed Price · Currency is HKD

16.30

+0.15 (0.93%)

Jul 31, 2026, 4:08 PM HKT

Qyuns Therapeutics Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	806.96	806.96	158.79	-	9.66	21.35
Revenue Growth	151.89%	408.18%	-	-	-54.74%	-
Gross Profit	714.41	714.41	92.19	-	9.66	21.35
Operating Income	330.13	330.13	-342.28	-514.26	-324.16	-179.34
Net Income	314.45	314.45	-335.57	-507.75	-298.19	-298.27
Earnings Per Share	1.41	1.41	-1.53	-2.47	-1.68	-2.57
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
The People's Republic of China (The "PRC")	104.56	104.56	158.79
The United States	197.8	197.8	-
Switzerland	504.6	504.6	-
Total	806.96	806.96	158.79

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	1,043	1,043	556.55	377.26	614.73	620.72
Total Debt	580.01	580.01	527.6	346.06	295.25	290.26
Net Cash (Debt)	462.6	462.6	28.96	31.2	319.48	330.46
Net Cash Growth	-	1497.61%	-7.18%	-90.23%	-3.32%	-
Net Cash Per Share	2.07	2.07	0.13	0.15	1.80	2.84

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	399.85	399.85	-186.09	-300.68	-225.21	-122.58
Capital Expenditures	-7.48	-7.48	-1.22	-7.87	-20.11	-57.98
Free Cash Flow	392.37	392.37	-187.31	-308.56	-245.33	-180.55
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	88.53%	88.53%	58.06%	-	100.00%	100.00%
Operating Margin	40.91%	40.91%	-215.55%	-	-3354.95%	-840.05%
Pretax Margin	38.09%	38.09%	-220.26%	-	-3233.09%	-1997.96%
Profit Margin	38.97%	38.97%	-211.33%	-	-3086.22%	-1397.13%
FCF Margin	48.62%	48.62%	-117.96%	-	-2539.08%	-845.71%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 1, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	10.42	12.11	-	-	-	-
P/FCF Ratio	8.34	9.70	-	-	-	-
PS Ratio	4.05	4.72	9.70	-	-	-